Milpro Deworming for Cats per tablet

Milpro Deworming for Cats per tablet Broad spectrum deworming tablet for kittens and adult cats. INDICATIONS: Milpro tablets are palatable broad spectrum anthelmintic tablets for kittens and cats. Milpro is indicated for the treatment and control of larval and adult stages of gastro-intestinal worms such as hookworms (Ancylostoma tubaeforme), roundworms (Toxocara cati and Toxascaris leonina) and for the treatment and control of all stages of tapeworm (Dipylidium caninum, Joyeuxiella pasqualei, Taenia spp., Echinococcus spp., Mesocestoides spp.) in Cats. DIRECTIONS FOR USE: Use only as directed. Kittens should be treated with Milpro at the age of 6, 8, 10 and 12 weeks of age, and then monthly up to 6 months of age. Nursing queens should be treated at the same time as their kittens. Depending on the body mass of the cat, practical dosing is as follows: Mass of kitten/cat to be treated Milpro Kittens (0,5 to 2 kg) From 0,5 kg to 1 kg ½ tablet From 1 kg to 2 kg 1 tablet Mass of cat to be treated Milpro Cats (more than 2 kg) From 2 kg to 4 kg ½ tablet From 4 kg to 8 kg 1 tablet > 8 – 12 kg 1 ½ tablet Milpro may be administered at any time with or without food. For complete absorption, Milpro can also be mixed into a portion of the daily food ration or hidden in pieces of meat. Where more than one cat is being treated, ensure that each pet is treated individually. EFFICACY: Milpro tablets contain milbemycin oxime, a nematode neurotransmission inhibitor, leading to paralysis of gastrointestinal nematodes and their subsequent expulsion, as well as praziquantel, a cestocide that interferes with muscular calcium metabolism of cestodes, leading to muscular contraction in these parasites and their expulsion or death. Milpro has been shown to be effective in treating mixed infections of immature and mature cestodes and nematodes of the following species. WARNINGS: For animal use only. Do not use in cats of less than 6 weeks of age and/or weighing less than 0,5 kg. Echinococcus spp. represents a hazard for humans (zoonosis). If Echinococcus spp. has been detected, specific treatment and follow-up guidelines should be followed, whist steps should be taken to safe-guard persons. At 6,5 times and higher dose rates (overdosing), mild transient clinical signs of tremors and ataxia may be observed in some cats. The symptoms will disappear within a day. No antidote is known. No studies have been performed in severely debilitated cats or individuals with compromised kidney or liver function. Milpro is not recommended for such animals and should only be used, following a risk/benefit assessment by the responsible veterinarian. Keep out of reach of children, uninformed persons and animals. Although this remedy has been extensively tested under a large variety of conditions, failure thereof may ensue as a result of a wide range of reasons. If this is suspected, seek veterinary advice and notify the registration holder. PRECAUTIONS: During treatment with Milpro, no other